Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2013 1
2014 1
2016 4
2017 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.
Pappa V, Bouchla A, Terpos E, Thomopoulos TP, Rosati M, Stellas D, Antoniadou A, Mentis A, Papageorgiou SG, Politou M, Kotanidou A, Kalomenidis I, Poulakou G, Jahaj E, Korompoki E, Grigoropoulou S, Hu X, Bear J, Karaliota S, Burns R, Pagoni M, Trontzas I, Grouzi E, Labropoulou S, Stamoulis K, Bamias A, Tsiodras S, Felber BK, Pavlakis GN, Dimopoulos MA. Pappa V, et al. Among authors: poulakou g. Microorganisms. 2021 Apr 11;9(4):806. doi: 10.3390/microorganisms9040806. Microorganisms. 2021. PMID: 33920489 Free PMC article.
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.
Maltezou HC, Basoulis D, Bonelis K, Gamaletsou MN, Giannouchos TV, Karantoni E, Karapanou Α, Kounouklas K, Livanou ME, Zotou M, Rapti V, Stamou P, Loulakis D, Souliotis K, Chini M, Panagopoulos P, Poulakou G, Syrigos KN, Hatzigeorgiou D, Sipsas NV. Maltezou HC, et al. Among authors: poulakou g. Vaccine. 2023 Mar 31;41(14):2343-2348. doi: 10.1016/j.vaccine.2023.01.067. Epub 2023 Feb 2. Vaccine. 2023. PMID: 36740558 Free PMC article.
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Green O, Rapti V, Tsakona M, Konstantinos T, Savva A, Kavatha D, Boumpas D, Syrigos K, Xynogalas I, Leontis K, Ntousopoulos V, Sakka V, Sardelis Z, Fotiadis A, Vlassi L, Kontogianni C, Levounets A, Poulakou G, Gaga M, MacLoughlin R, Stebbing J, Arber N, Antoniadou A, Tsiodras S. Grigoropoulos I, et al. Among authors: poulakou g. Respir Res. 2024 Apr 1;25(1):151. doi: 10.1186/s12931-024-02759-5. Respir Res. 2024. PMID: 38561798 Free PMC article.
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron.
Ison MG, Popejoy M, Evgeniev N, Tzekova M, Mahoney K, Betancourt N, Li Y, Gupta D, Narayan K, Hershberger E, Connolly LE, Yalcin I, Das AF, Genge J, Smith M, Campanaro E, Hawn P, Schmidt P; STAMP Study Group. Ison MG, et al. Open Forum Infect Dis. 2023 May 24;10(6):ofad279. doi: 10.1093/ofid/ofad279. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37351456 Free PMC article.
Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.
Antoniadou A, Kanellakopoulou K, Kanellopoulou M, Polemis M, Koratzanis G, Papademetriou E, Poulakou G, Giannitsioti E, Souli M, Vatopoulos A, Giamarellou H. Antoniadou A, et al. Among authors: poulakou g. Scand J Infect Dis. 2013 Jun;45(6):438-45. doi: 10.3109/00365548.2012.760845. Epub 2013 Jan 22. Scand J Infect Dis. 2013. PMID: 23336730
13 results